(Q60221566)

English

Optimization of immune responses induced by therapeutic vaccination with cross-reactive antigens in a humanized hepatitis B surface antigen transgenic mouse model

article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22591777%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Optimization of immune responses induced by therapeutic vaccination with cross-reactive antigens in a humanized hepatitis B surface antigen transgenic mouse model (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22591777%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Maryline Bourgine

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22591777%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22591777%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

author name string

Ophélie Godon

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22591777%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Gerardo Guillen

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22591777%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Marie-Louise Michel

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22591777%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Julio Cesar Aguilar

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22591777%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

language of work or name

0 references

publication date

15 May 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22591777%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22591777%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

430

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22591777%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22591777%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

10-19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22591777%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Development of a nasal vaccine for chronic hepatitis B infection that uses the ability of hepatitis B core antigen to stimulate a strong Th1 response against hepatitis B surface antigen.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.04.007

7 January 2021

Specific expression of hepatitis B surface antigen (HBsAg) in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.04.007

7 January 2021

Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.04.007

7 January 2021

Kinetics of hepatitis B surface antigen-specific immune responses in acute and chronic hepatitis B or After HBs vaccination: Stimulation of thein vitroantibody response by interferon gamma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.04.007

7 January 2021

Hepatitis B virus immunopathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.04.007

7 January 2021

Immune response induced by a linear DNA vector: influence of dose, formulation and route of injection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.04.007

7 January 2021

Hepatitis B surface antigen gene expression is regulated by sex steroids and glucocorticoids in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.04.007

7 January 2021

Viral Clearance Without Destruction of Infected Cells During Acute HBV Infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.04.007

7 January 2021

Should a new tuberculosis vaccine be administered intranasally?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.04.007

7 January 2021

Heterologous prime-boost vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.04.007

7 January 2021

The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.04.007

7 January 2021

Induction of anti-hepatitis B surface antigen (HBsAg) antibodies in HBsAg producing transgenic mice: a possible way of circumventing "nonresponse" to HBsAg.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.04.007

7 January 2021

Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.04.007

7 January 2021

DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.04.007

7 January 2021

Therapeutic vaccines and immune-based therapies for the treatment of chronic hepatitis B: perspectives and challenges

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.04.007

7 January 2021

The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.04.007

7 January 2021

Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell site

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.04.007

7 January 2021

Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.04.007

7 January 2021

A mouse model of human adaptive immune functions: HLA-A2.1-/HLA-DR1-transgenic H-2 class I-/class II-knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.04.007

7 January 2021

Identification of novel HLA-DR1-restricted epitopes from the hepatitis B virus envelope protein in mice expressing HLA-DR1 and vaccinated human subjects

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.04.007

7 January 2021

The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.04.007

7 January 2021

A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.04.007

7 January 2021

HLA-B*0702 transgenic, H-2KbDb double-knockout mice: phenotypical and functional characterization in response to influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.04.007

7 January 2021

Breaking tolerance in hepatitis B surface antigen (HBsAg) transgenic mice by vaccination with cross-reactive, natural HBsAg variants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.04.007

7 January 2021

Analyzing real-time PCR data by the comparative C(T) method

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.04.007

7 January 2021

Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.04.007

7 January 2021

Acute phase HBV-specific T cell responses associated with HBV persistence after HBV/HCV coinfection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.04.007

7 January 2021

Mutations in the carboxyl-terminal domain of the small hepatitis B virus envelope protein impair the assembly of hepatitis delta virus particles.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.04.007

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIROL.2012.04.007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22591777%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22591777%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q60221566&oldid=1903418415"